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Abstract
Purpose: To explore and describe lymphoma survivors’ thoughts and perceptions of
the components of a nurse-led lymphoma survivorship clinic intervention.
Methods: An exploratory, qualitative descriptive study using interviews from 10
participants who had transitioned post-treatment into the survivorship phase via a
nurse-led lymphoma survivorship clinic intervention.
Results: Thematic analysis revealed three major themes: Reassurance and
individualised care; Information and support; and Empowerment. Participants
described the reassurance they gained from having contact with a health professional
post-treatment who individualised information and support. A survivorship care plan
and treatment summary was developed for this study and was believed to be very
patient-centred and helpful. This enabled participants to take back control of their
health and well-being and to rebuild confidence.
Conclusions: In this study, participants expressed a need for patient-centred follow-up
care that addressed their concerns and supported them in the survivorship phase to
get their life back on track. Nurse-led follow-up may offer a viable model of posttreatment survivorship care to lymphoma cancer survivors.
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Introduction
Lymphomas are haematological cancers that originate from the lymphatic
system, and are mainly categorised as either Hodgkin (HL) or non-Hodgkin lymphoma
(NHL) (American Cancer Society, 2014). Worldwide, lymphomas represent the sixth
most commonly diagnosed cancer (Surveillance Epidemiology and End Results
(SEER), 2014). Australian incidence is increasing with an estimated 6,323 cases
expected in 2017, which will equate to 4.6% of all cancer cases (Cancer Australia,
2017). However, developments in treatment and supportive care options such as
chemotherapy, haematopoietic stem cell transplantation, radiotherapy and targeted
therapies have improved five year survival to 76% (Cancer Australia, 2017). With
increased remission and survival rates, many survivors experience issues and
concerns, called unmet needs, which can impact quality of life and well-being (Carey
et al., 2012; Sant et al., 2014). These can relate to issues such as: fatigue; poor
nutrition; exercise capacity; cognition impairment; fear of recurrence; fertility,
relationships; finances; employment; and insurance (Taylor et al., 2015; van der Poel
et al., 2014). Health can be further compromised by late effects of treatment such as
cardiovascular disease and second cancers (Grinyer, 2010; Ng et al., 2011; Travis et
al., 2012), often experienced earlier than the general population (Panek-Hudson,
2013).
Haematological survivorship studies mainly report on mixed haematological
samples regardless of variations in clinical features, treatment, curability and relative
survival (Hall, Campbell, et al., 2013; Lobb et al., 2009; McGrath, 2014). A study of
lymphoma (n=236) and myeloma (n=178) survivors on anxiety, depression and unmet
needs in the early survivorship period (under two years) reported decreasing anxiety
and depression rates in the myeloma cohort and increasing rates in the lymphoma
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cohort (Oberoi et al., 2017). The authors indicated a need for cohort specific studies,
especially in the early survivorship period (Oberoi et al., 2017) to ensure targeted
support. Lymphoma only studies often reflect a survivorship period beyond two years
at assessment (Ferrer, Huedo-Medina, Johnson, Ryan, & Pescatello, 2011; Friedman
et al., 2010; Oerlemans et al., 2014), which may not reflect the unique needs of those
who have recently completed treatment, limiting generalisability. A recent study by the
authors (Monterosso et al., 2017) reported on focus groups with lymphoma survivors
(n=17), the majority (n=13, 76%) who were 12-30 months post-treatment completion.
Participants recounted unmet needs related to information, coping strategies and
support, especially when transitioning into survivorship. Findings suggested cancer
nurse coordinators could be a feasible approach to delivering structured,
individualised support early post-treatment (Monterosso et al., 2017).
Nurse-led models of survivorship care have been proposed to transition
patients post-treatment and have demonstrated acceptable outcomes in haematology
cohorts (Gates et al., 2015; Howell et al., 2012; John & Armes, 2013). As a minimum,
nurse-led models should include: administration of survivor-specific needs
assessments to identify patient concerns (McDowell et al., 2010; Stricker et al., 2011);
development and delivery of a survivorship care plan and treatment summary
(SCPTS), to guide holistic follow-up (Clinical Oncology Society of Australia, 2016;
MacMillan Cancer Support & NHS Improvement, 2010; McCabe, Bhatia, et al., 2013);
and support to assist survivors to take ownership of their health and well-being
(Bodenheimer et al., 2002; Kuijpers et al., 2013). To date, studies that have tested
nurse-led models of care have focused on survivors of common cancers (breast,
prostate, colon) (Jefford et al., 2016; Maly et al., 2017; Taylor et al., 2015), been based
in acute care settings, used long consultations, and involved more frequent patient
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contact (Cooper et al., 2010; De Leeuw & Larsson, 2013), which may preclude
generalisability to other cancers or limit economic viability.
In order to provide lymphoma survivors with specific and responsive supportive
care, the unique issues and unmet concerns of this cohort need to be assessed in the
early survivorship period (under one year). The aim of this sub-study was to provide
qualitative semi-structured interview data from a sample of participants who had been
randomised to the intervention group of the Care After Lymphoma (CALy) phase II
randomised controlled trial study (RCT) (Taylor et al., 2016). The RCT aimed to
develop and test a nurse-led lymphoma survivorship clinic (NLSC) intervention to
assist participants transitioning from treatment completion into the early survivorship
phase. This study will add to the limited literature that exists in lymphoma specific early
survivorship.

Methods
Methodological framework
A qualitative descriptive methodology was utilised to provide a comprehensive
summary of a specific experience by the participants (Neergaard, Olesen, Andersen,
& Sondergaard, 2009; Sandelowski, 2000), using a semi-structured interview design.
The interview schedule consisted of the same open-ended questions and was
developed by the researchers. To ensure participants felt able to express themselves
and their perceptions freely, interviews were conducted by an experienced
independent researcher.
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Sample and setting
A purposive sample of lymphoma patients from a large tertiary hospital cancer
centre in Perth, Western Australia were recruited from the intervention group of the
RCT. A non-probability purposive sampling provides rich information from participants
who have the greatest amount of in-depth knowledge and experience of a particular
circumstance or event (Patton, 2014). Only participants who had completed all
aspects of the NLSC intervention were approached by the survivorship cancer nurse
conducting the clinic intervention. These participants had completed four measures:
Short Form Survivor Unmet Needs Survey (SF-SUNS); Depression Anxiety Stress
Scale (DASS21); Mini Mental Adjustment to Cancer Scale (Mini-MAC); and Patient
Empowerment Scale at three time points; baseline (prior to randomisation), 3 months
and 6 months. At the first NLSC appointment (approximately one week after baseline),
participants completed and received an individualised lymphoma SCPTS, developed
for this study (Taylor et al., 2016). Participants’ GP were sent a copy. A motivational
interview technique was used to provide evidenced-based information, advice and
support at the first intervention appointment and reinforced with additional resources
and support as required over the next two appointments.
All participants approached agreed to be interviewed. Each participant was nine
months’ post-treatment completion and the sample reflected an equal gender
distribution and range of ages. Data saturation was achieved after ten interviews.

Interviews
The study was approved by the relevant hospital and university human
research ethics committees. Informed written consent was obtained by all participants
prior to interview scheduling. Interviews were conducted from February 2016 to May
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2017 and occurred after the last NLSC appointment. Telephone interviews were
conducted at a time convenient for the participant and were digitally recorded. The
following are examples of the interview questions: ‘Did you have any concerns or
needs not addressed by any of the questions?’; ‘What aspects of the clinic would you
want to stay the same for future patients?’; ‘Would you recommend the clinic to other
patients finishing treatment?’; ‘How do you feel about having the health concerns,
goals and actions individualised to yourself?’; and ‘Overall how useful was the SCPTS
to you?’ Interviews were transcribed verbatim, de-identified and an identifier code
applied. Digital recordings and transcribed interviews were saved in a passwordprotected file on a secure server. After the first three interviews, the question order
was slightly altered to enhance the flow of the interview.

Data Analysis
Interview transcripts were imported into NVivo 11 (NVivo 11, 2016) to facilitate
management of data and completion of the analysis. Thematic analysis was used to
establish patterns and themes within the text (Grbich, 1998; Patton, 2014; Smith,
2007). Thematic analysis allows for participant diversity of ideas and perceptions
(Smith, 2007), thus providing a depth of information regarding the personal impact of
the NLSC on the participant. Subthemes were developed from the data, and allowed
for a logical organisation of the themes that emerged. The criteria of credibility,
auditability and fittingness were applied to the data analysis process to ensure rigor
(Beck, 1993). Credibility was maintained by triangulation with another member of the
research team (Beck, 1993) to ensure independent reading and analysis of the
transcripts by KT and CB who allocated codes and themes to the generated data
(Braun & Clarke, 2006). The researchers met to discuss the codes and any
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discrepancies before consensus on emerging themes was reached. The ample use of
extracts or quotes from the data demonstrated fittingness to the agreed codes. A
comprehensible audit trail maintained auditability, demonstrated by documentation of
research planning through to analysis, and through a reflective discourse and debrief
process with colleagues.

Results
Participants
Ten semi-structured interviews were conducted with all participants willing to
share an opinion for each of the interview guideline areas. Demographic and disease
information is shown in Table 6.3.1. There were equal numbers of males and females,
with similar age range (24 – 74 years) and lymphoma type. The majority of participants
resided within the metropolitan area (n=8, 80%), were working (n=6, 60%), were
married or defacto (n=6, 60%) and had a university degree or trade qualification (n=8,
80%).
Time elapsed from end of study to interview ranged from 1 to 26 days (mean
6.5 days, SD 7.8 days). The majority of interviews (n=8) were done within 5 days. No
time limit was set and interviews ranged from 17 minutes through to 48 minutes (mean
30.5 minutes).
Table 1 Demographic Characteristics for Interview Participants (n=10)
Characteristics

Age group at baseline
24-25
48
65-74
Lymphoma diagnosis
Non-Hodgkin

Males
n=5
(50%)

Females
n=5 (50%)

2
1
2

2
1
2

2

2
8

Hodgkin
Highest level of education
Secondary school or less
Trade / vocational college
University
Employment status
Working
Retired
No return to work date
Marital status
Single
Married / defacto
Divorced
Residence
Metropolitan
Regional

3

3

1
2
2

1
2
2

4
1
-

2
2
1

1
4
-

2
2
1

4
1

4
1

Themes
Three major themes emerged from analysis and coding of data: Reassurance
and individualised care; Information and support; and Empowerment. Subthemes
have been included to add clarity.

Reassurance and individualised care
Overall, the NLSC was well received and deemed a positive experience for
participants, although it would have been reassuring to know about the clinic
intervention during treatment. The assessment questionnaires and the SCPTS were
perceived to facilitate individualised care.

Timing of support
Most participants indicated they would have liked knowledge of the clinic
intervention during treatment so they could feel reassured that someone was still
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interested in supporting them and they were ‘not going to be abandoned’. This would
take the form of a contact person they could trust.
“Just knowing that I was still going to get some support” F_25yo_HL
“But to know that look, don’t worry, after treatment you are going to see a nurse,
that would have been very calming for me” F_64yo_HL

The use of questionnaires to elicit unmet needs and concerns
Questionnaires were used to elicit unmet needs and areas of concern that could
be discussed with participants at the NLSC appointment. Participant responses served
as a focus for the follow up appointment. Feedback about the questionnaires indicated
some questions were hard to answer.

“Sometimes I found that I couldn’t say yes or no to the questions, because they
didn’t apply I suppose, and I had to answer” F_64yo_HL

Nonetheless, the questionnaires were able to cover aspects thought to be
important to participants’ overall wellbeing, as one said,

“They covered a multitude of the different things like your emotional well-being,
mental well-being and physical well-being, all the things that you know you can
struggle with” F_24yo_HL

The supportiveness of the intervention
All participants wanted the intervention structure to remain the same, describing
the one-to-one, personalised nature of the intervention a valuable opportunity to talk
to someone who was not family, friends or a doctor. They described being listened to
and ‘feeling safe’ to ask questions on a range of topics, especially questions they felt
they could not ask their haematologist. Participants indicated support was
individualised and felt reassured they could get their life back on track.
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“The one-on-one was really helpful because then you felt like you could pretty
much ask anything, or talk about anything, and you didn’t feel like there would be
other people around to listen to your private conversations. A safe space, ask
questions and get reassurance and the right answers. That was good” F_24yo_HL
“Someone that you can speak to and address the problems that you don’t get the
time with the doctors to talk about” F_64yo_HL

Another participant also commented on how he could discuss other aspects of the
cancer experience. He said,

“What I particularly liked was the opportunity to have a conversation around things
other than treatment. Dealing with some of the fears that you may have that you
didn’t feel like you could ask your specialist about. Or where do I go for
complementary therapies. The kind of questions that specialists I don’t think are
necessarily geared for. Or don’t have time really to cover. The ability to have a
chat to a nurse that can help you through the next part of the journey”
M_48yo_NHL

A couple of participants indicated that the intervention should have been
conducted according to patient preferences. This included a preference for the NLSC
to be away from the hospital and closer to their home.

“We should be providing services close to home where possible and I think there
are some really great opportunities for the survivorship study to get out into the
community even though they are still run by the hospital” M_48yo_NHL
Although two participants found returning to the hospital traumatic, they felt the
NLSC experience helped them to overcome their aversion as it was felt to be a safe
place they could communicate their fears and receive reassurance.

“The torture as a result of the treatment – going back to the hospital made me feel
all that. It actually helped me deal with the fact that I can go to the hospital and not
feel sick – so there was a positive to” M_48yo_NHL
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Nurse contact and rapport
It was also felt contact should have been more frequent with telephone support
between face to face visits, to provide extra support and to ‘check-in’ with the
participant.

“I think you need to make them a bit closer together – a bit more frequent. And
also make it where patients can choose. Make it more patient-driven - where the
patient tells you how often they want to see or talk to someone” F_48yo_NHL
There was also an indication that many wanted the contact to go beyond the study
timeframe. As one participant said,

“I don’t feel like I am on my own steam yet. I am thinking 2 years before I have got
my confidence and hopefully my health back” F_64yo_HL
All participants described the relationship with the nurse who ran the intervention
as comfortable and flexible, and felt they could call or speak to her with any issues if
they wanted to. Participants provided comment and perceptions of the nurse as
follows:

“And she did explain things so that I understood them more. She was really good
at making you feel relaxed” F_48yo_NHL
“You felt like you had enough time to talk about and ask questions you didn’t feel
rushed and I think that was really good” F_24yo_HL

Survivorship care plan and treatment summary
The written patient-centred SCPTS was described as reassuring when it guided
follow-up and for keeping on track with healthy lifestyle behaviours.

“Yes, it was good because it is reassuring, it is a guideline of what to do which I
needed and knowing what to look out for and should be doing” F_64yo_HL
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Feedback from participants regarding the SCPTS being sent to the GP indicated
only two GPs discussed the SCPTS with them. Other participants indicated they either
had not seen the GP or the GP acknowledged receipt but did not discuss.

Information and support
Participants appreciated the opportunity to discuss, record and receive written
individualised information, support and resources. Although some information such as
late effects was confronting at the time, it was nevertheless appreciated. All felt the
information received at the NLSC was relevant and appropriate because it was tailored
to their unique needs. Most felt they had not received this information or support from
the treating team, however, it was acknowledged that possibly verbal information had
been given but not retained.

Individualisation of the SCPTS
Participants liked the individualisation of the health concerns, goals and actions,
and the accompanying written information and/or contacts.
“When I did have a concern, I was given printed notes about those issues and I
think that is really good. Because I do have trouble with my memory now, and I
can go back over those notes and sometimes it is like reading it anew, you know”
F_64yo_HL
The treatment summary was well-received with most participants describing it as
‘good to have’, especially as a tool for communication with other health professionals.

“I think it was useful to sit down and have that initial meeting. I think it was really
good that it was sent to my GP” F_25yo_HL
However, one participant was unsure of the value to himself,
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“But I think this kind of treatment summary is the sort of thing I would give to my
GP, or if I am seeing a new Dr, or if I was travelling and I got sick. I almost feel like
it’s less useful for me, but more useful for other people” M_24yo_HL

One participant felt the terminology related to the disease location could have
been put in simpler language and this helpful recommendation was utilised for
subsequent treatment summaries.

“Sometimes you don’t always understand the medical terms so I think putting it
into more simpler language would be a bit more helpful” F_48yo_NHL
Late effect information
The potential late effect information given on the SCPTS was individualised to
each participant. It came as a shock to many that heart disease and other cancers, for
example, were possible consequences of the treatment received.

“Well that was a bit of a shock to me because they hadn’t been mentioned prior to
the treatment. … but at the same time, it was probably easier on me not knowing
anyway” F_64yo_HL
Participants appreciated having the information and felt it could help with GP
consultations, specifically around planning of health management into the future.

“That gave me something to go to my GP with and go okay I think I need to monitor
this and this. And it helped me set out a care plan with my Dr as well” F_48yo_NHL
“It is always a bit overwhelming, but I think it is a good way to highlight the possible
things that could happen. I think it reduces you’re stress because you are not just
in the dark about it. I think it is really important for yourself and the GP. If anything
does change you know at least you are going to get it early” F_24yo_HL
One participant indicated they had heard the potential late effect information at
diagnosis and another described being told there were some possible late effects after
she had completed treatment,
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“Oh, he just briefly spoke about ‘you just need to be careful, you need to look after
your skin, you need to do annual breast checks, you need to look after your heart.
You know there is a possible risk you could get these problems in the future’. That
is sort of how he mentioned it” F_24yo_HL
Neither participant had received written information and did not feel they knew
how to follow-up these risk factors. This was an important consideration when
developing the SCPTS to ensure follow-up suggestions for the GP and participant
were given.

“[GP] just asked me to come in and discussed it with me and then he kind of just
saved it and then he linked me in with support services to make sure I was
monitoring all of my side-effects, so I think he thought it was good” F_25yo_HL

Empowerment
Most participants perceived the intent of the NLSC was to assist with
transitioning away from a reliance on the treating team, to taking responsibility for
monitoring and seeking support.
Nurturing empowerment
All participants described the SCPTS as useful and perceived it as a means to
remind them to ‘stay on track’ with healthy lifestyle behaviours or for encouragement
with achieving their goals.

“It just kind of helped remind me of my goals, and every time I had the meeting
with [KT], it was like a kind of thing to remember my goals and I thought was a
really beneficial thing” M_24yo_HL
Although one participant described the initial discussion and plan as helpful, she
felt she should not have had to seek out services and arrange appointments.
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“Maybe actually getting linked into the services they talk about. Rather than just
getting the information and being left with it, it was kind of like I had to go and seek
it out myself. I think it would have been really helpful to have someone contact
me” F_25yo_HL
It appeared she did not want to take responsibility for her follow-up care. The
remaining participants described understanding and appreciating the need to take
back control of their health and well-being. They described the opportunity to discuss
and write down their own health concerns, health goals and the actions they planned
to take with a health professional as confidence building and assisted in increasing
their positivity post-treatment completion.
“There are definitely days where you go thru and you start to question yourself,
but being able to talk to someone about it made me feel more confident about
being finished” M_25yo_HL
“I started thinking a bit more positive” M_71yo_HL
Participants noted that having the opportunity to record and discuss participantspecific issues had personalised both the appointment and the SCPTS.

“It identified what you personally were worried about and it wasn’t just a general
thing that everyone can be worried about, but it was specific to you. And then
having the specific needs addressed with a certain plan or the actions column that
you could put in place. I think that was really helpful because you see how you
could be proactive about things” F_24yo_HL
Monitoring progress
Participants felt the follow-up over the next six months in the NLSC allowed them
to monitor their progress and see how they were going.

“That was good. It was something to monitor my progress and it feels more
personal” M_25yo_HL
“It sort of crystallises your thinking for the future. If you don’t do something like that
you tend to drift along day to day” F_74yo_NHL
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Receiving written and contact information for support allowed participants to
engage and take ownership for how and when they dealt with their goals and
concerns. Even when issues remained unmet, having the issue normalised was
equally important.

“Well the fatigue and the memory [problems] I have still got. It was useful to find
that other people suffer the same things, that I am not alone on that!” F_64yo_HL
Usefulness of general health information
Participants received general health and screening information and felt it was
helpful. Most read it again at home, then put it aside. They felt the value was in having
it to refer to if needed.

“I think that it is really good to get the information and just have it there. I thought
that was very handy” F_24yo_HL
This document was not sent to the GP, as GPs involved in evaluating the SCPTS
for content clarity, internal consistency and content validity, indicated they knew this
information and did not want it. It was noteworthy that two participants had given it to
the GP and it had guided follow-up care.

“I basically took all the information into my GP and let him read thru it and he used
it to help guide my care plan in the right direction” F_48yo_NHL

Discussion
This study contributes to the growing body of cancer-specific survivorship
literature. The current model of specialist follow-up care for cancer survivors is
inadequate, with many survivors experiencing unmet needs that can remain poorly
addressed throughout the survivorship continuum (De Leeuw & Larsson, 2013). It is
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essential survivorship care incorporates an awareness of treatment and disease, longterm and late effect risks, as well as healthy lifestyle behaviours (Taylor et al., 2015),
and facilitates communication amongst all health professionals and the patient and
family. Expertise in the provision of health promotion, support and information has
always been the purview of cancer nurses (Jackson et al., 2013), therefore nurse-led
models should be considered within any proposed model of survivorship care.
This study involved a cohort of lymphoma participants and specifically targeted
those in the early survivorship phase (first nine months’ post-treatment). Studies that
involve a single subtype of haematological cancer are important in ascertaining the
psychosocial and supportive care interventions that are specific and most appropriate
(Oberoi et al., 2017). Assessing and providing an intervention in the early survivorship
period has been shown to lead to a reduction in the unmet needs as survivors continue
beyond five years (McDowell et al., 2010).
Participants described having time within the NLSC appointment to ask
questions and seek individualised support as fundamentally helpful. An important point
of difference with medical follow-up where participants perceived the specialist as too
busy, or perhaps not interested when they were seeking reassurance and support.
Interestingly, some participants would have preferred a follow-up appointment away
from the hospital, an important consideration with future planning of nurse-led clinics.
Participants had not previously met the nurse who provided the intervention, she is
however, a cancer nurse coordinator with extensive haematology/oncology nursing
and counselling experience and qualifications. A health professional who can quickly
build a strong and positive rapport allows participants a greater opportunity to explore
their own unmet needs (Ross, 2013). This may be why participants responded
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favourably to the intervention and is important when considering nurse-led models of
survivorship care.
Empowering participants with an individualised SCPTS that provided disease
and treatment knowledge, and allowed them to assume responsibility for their future
health and well-being (Taylor & Monterosso, 2015), was described as helpful from all
participants. The expectation of younger survivors living longer with potential issues is
important (Jabson & Bowen, 2013), nevertheless all participants in this study,
regardless of age, appreciated the follow-up guidance they could discuss and
implement with their GP. Information on general health and screening allowed
participants a sense of independence of when and how they would seek follow-up. Of
particular importance to participants was the opportunity to personalise the SCPTS
and concentrate on what was important to them as they moved forward after treatment
had completed. Conversely, our study revealed a small subset of participants who
were not ready to take back control of their future health and well-being. It is important
to acknowledge those patients and provide individualised support that meets their
needs at the time, without building further dependency in the survivorship phase.
Survivorship literature highlights the concept of ‘teachable moments’ (Alfano et
al., 2012; Grant & Economou, 2008; Hewitt et al., 2005; Panek-Hudson, 2013) at the
end of active treatment to support and promote patient participation in healthy lifestyle
behaviours. It was thought that participants in this study would need to be encouraged
to engage in healthy lifestyle behaviours. However, it was evident that participants did
feel a need to improve their health, and for some, change their lifestyle to adopt
healthier lifestyle behaviours they had not been able to do during the stress of
treatment. These participants particularly described the opportunity to revisit the
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SCPTS over the preceding months allowed them to monitor and reflect on their
achievements and help them to keep focused on their goals.

Limitations
This study reflects the views of a subset of lymphoma participants who
underwent a nurse-led clinic survivorship intervention and therefore could not be
generalisable to the wider survivorship population who have experienced a nurse-led
clinic. Nonetheless, the use of qualitative interview research allowed an opportunity to
gain a deeper understanding of the experiences of this select group. The findings are
presented to help build research that is based on patient experience and feedback.
The small number of participants is not a methodological limitation in qualitative
research when data saturation is reached.

Conclusion
The interviews were conducted to ascertain the participant’s perception of the
efficacy and value of the components of the nurse-led intervention and to highlight any
issues or challenges for this cohort that could be better addressed in the future.
Survivorship care offered by nurses may address the patient-perceived unmet needs
at the conclusion of active treatment. Participants indicated the need for security in
knowing there would be support when treatment completed and would likewise value
the opportunity to have their concerns heard. An individualised SCPTS that empowers
survivors to address healthy lifestyle issues and provide a follow-up guide for late
effects of the disease and treatment assists in refocusing responsibility back to the
patient. Nurse-led survivorship care may offer an acceptable model to deliver patient-
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centred post-treatment follow-up. This model allows the time required to individualise
and tailor supportive survivorship care.
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